CDC42缺陷导致复发性种植失败患者子宫内膜基质细胞衰老
本研究比较71例生育力对照组与37例复发性种植失败(RIF)患者子宫内膜,发现RIF组子宫内膜基质衰老和纤维化增加且CDC42表达降低(P < 0.001)。体外敲低CDC42通过激活Wnt信号通路诱导子宫内膜基质细胞衰老并损害蜕膜化,Wnt抑制剂XAV-939可部分纠正上述缺陷。
要点
- RIF患者子宫内膜基质衰老和纤维化增加,伴CDC42表达降低(P < 0.001)。
- 敲低CDC42通过AKT/GSK3β/β-catenin激活Wnt信号,诱导基质细胞衰老并损害蜕膜化。
- Wnt抑制剂XAV-939可部分纠正CDC42缺陷所致的子宫内膜衰老并改善蜕膜化和滋养细胞侵袭。
核心结论
- CDC42缺陷通过激活Wnt信号通路导致子宫内膜基质衰老和蜕膜化缺陷,损害RIF患者的子宫容受性。
- Wnt信号抑制剂可能作为缓解子宫内膜衰老的潜在治疗药物。
研究设计与样本
- 收集71例生育力对照组和37例RIF患者的子宫内膜样本,验证CDC42表达与子宫内膜衰老的关联。
- 从无子宫内膜并发症且计划行IVF的患者子宫内膜活检中分离原代子宫内膜基质细胞(EnSC),经腺病毒介导CDC42敲低并诱导蜕膜化以探讨机制。
- 使用Wnt抑制剂XAV-939纠正子宫内膜衰老和蜕膜化缺陷。
主要发现
- RIF患者子宫内膜中基质衰老和纤维化水平显著增加,同时基质CDC42缺陷(P < 0.001)。
- 敲低CDC42有效诱导EnSC早衰,导致蜕膜化过程中衰老EnSC异常积累和胶原沉积。
- EnSC中CDC42缺陷抑制蜕膜化分化和对滋养细胞的容受性。
- 转录组分析显示Wnt信号激活是CDC42缺陷EnSC的关键下游改变。
- CDC42与AKT竞争性相互作用,阻碍GSK3β与AKT结合;敲低CDC42增加AKT介导的GSK3β磷酸化,使Axin-GSK3β降解复合物失活,导致β-catenin积累和核转位。
局限性
- 本研究基于体外细胞培养。
- 需要在敲除小鼠模型和人子宫内膜组装体中进一步研究CDC42调控的子宫内膜衰老。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the downregulation of cell division cycle 42 (CDC42) protein in endometrial stroma lead to endometrial senescence in patients with recurrent implantation failure (RIF), and what is the potential mechanism? SUMMARY ANSWER: CDC42 deficiency causes endometrial stromal senescence and decidualization defects, impairing uterine receptivity of RIF patients, via activation of Wnt signaling pathway. WHAT IS KNOWN ALREADY: Uterine aging is unique due to the cyclic remodeling and decidualization of endometrial tissue. Several transcriptomic studies have reported increased senescence in the endometrium in young patients with RIF. Our previous transcriptomic sequencing study discovered that endometrium from women with RIF showed downregulation of CDC42, which is an essential molecule affected by various senescence-related diseases. STUDY DESIGN, SIZE, DURATION: The endometrial samples of a total of 71 fertile control patients and 37 RIF patients were collected to verify the association between CDC42 expression and endometrial senescence of RIF patients. Primary endometrial stromal cells (EnSCs) were isolated from endometrial biopsies taken from patients without any endometrial complications and planning to undergo IVF, then subjected to adenovirus-mediated CDC42 knockdown and decidualization induction to explore the detailed mechanism by which CDC42 governs stromal senescence and decidualization. Wnt inhibitor XAV-939 was used to correct the endometrial senescence and decidualization defect. PARTICIPANTS/MATERIALS, SETTING, METHODS: Senescence was determined by cell cycle arrest markers (e.g. P16, P21, and P53), SASP molecules (e.g. IL6 and CXCL8), and SA-β-gal staining. Masson's staining and Sirius Red staining were used to detect the endometrial fibrosis. Decidualization was evaluated by the mRNA expression and protein secretion of PRL and IGFBP1, F-actin immunostaining, and the BeWo spheroids 'in vitro implantation' model. Methods used to assess cell function included adenovirus transduction, RNA-sequencing, bioinformatic analysis, western blotting, RT-qPCR, ELISA, and immunofluorescence. MAIN RESULTS AND THE ROLE OF CHANCE: Here, we observed remarkably increased levels of stromal senescence and fibrosis, along with stromal CDC42 deficiency, in the endometrium of patients with RIF (P < 0.001). Knockdown of CDC42 effectively induced premature senescence in EnSCs, leading to aberrant accumulation of senescent EnSCs and collagen deposition during decidualization. CDC42 deficiency in EnSCs restrained the decidualization differentiation and receptivity to trophoblast cells. Transcriptomic analysis revealed Wnt signaling activation as a critical downstream alteration in CDC42-deficient EnSCs. Mechanistically, CDC42 interacted with AKT competitively to impede the binding of GSK3β to AKT. Knockdown of CDC42 increased AKT-mediated phosphorylation of GSK3β to inactivate the Axin-GSK3β destruction complex, leading to accumulation and nuclear translocation of β-catenin. Importantly, Wnt signaling inhibitors partially corrected the endometrial senescence caused by CDC42 deficiency, and improved both decidualization and trophoblast invasion. LARGE SCALE DATA: RNA-seq data sets generated in this study have been deposited at the NCBI database with BioProject accession number PRJNA1102745. LIMITATIONS, REASONS FOR CAUTION: The present study was based on in vitro cell cultures. Further studies involving CDC42-regulated endometrial senescence are needed in knockout mice model and human endometrial assembloids. WIDER IMPLICATIONS OF THE FINDINGS: In addition to uncovering endometrial senescence in RIF, our findings underscore the significance of CDC42 in modulating EnSC senescence to maintain the decidualization function, and suggest Wnt signaling inhibitors as potential therapeutic agents for alleviating endometrial senescence. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China [82271698 (R.J.), 82030040 (H.S.), 82288102 (H.W.), and 82371680 (G.Y.)]; the Natural Science Foundation of Jiangsu Province [BK20231117 (R.J.)]; and the Medical Science and Technology Development Foundation of Nanjing Department of Health [YKK23097 (Y.Z.)]. The authors declare no potential conflicts of interest.
引用
- Tang X, Zhu Y, Cao Z, et al. CDC42 deficiency leads to endometrial stromal cell senescence in recurrent implantation failure. Hum Reprod. 2024. PMID: 39487595. doi:10.1093/humrep/deae246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。